Loading…
avatar for Theresa Mullin

Theresa Mullin

FDA
Associate Director for Strategic Initiatives, OCD, CDER
Principal advisor on strategy including CDER international cooperation and harmonization, application of decision science, and other initiatives. Leads FDA Patient Focused Drug Development, and heads the FDA delegation to ICH. Previous work includes leading FDA negotiations for 2002, 2007, 2012 and 2017 cycles of reauthorization of the Prescription Drug User Fee Act, providing nearly $1B in annual funding for new drug review. She has received the SES Presidential Rank Award for Distinguished Service in 2011, Presidential Rank Award for Meritorious Service in 2006, and the FDLI Distinguished Service and Leadership Award in 2017.